VALUTAZIONE DELLE ROSETTE E IN PAZIENTI PORTATRICI DI CARCINOMA ENDOMETRIALE. (STUDIO LONGITUDINALE DI 43 CASI)

P. F. Bolis; S. Guaschino; M. Franchi; R. Maccario

VALUTAZIONE DELLE ROSETTE E IN PAZIENTI PORTATRICI DI CARCINOMA ENDOMETRIALE. (STUDIO LONGITUDINALE DI 43 CASI)

Translated title of the contribution: The significance of rosette E in women with endometrial cancer: A longitudinal study of 43 cases

P. F. Bolis, S. Guaschino, M. Franchi, R. Maccario

IRCCS Fondazione Policlinico San Matteo

Research output: Contribution to journal › Article › peer-review

Abstract

The percentage of Rosette E does not show significant modification in the patients affected with adenocarcinoma of endometrium stage I and II in comparison with a control group. We did not find any modification at the diagnosis, during the follow-up, considering the stage, the cellular differentiation, the myometrial infiltration and the presence or absence of relapses. We think that the endometrial carcinoma can originate and progress independently from the immunological situation of the patient, or that the Rosette E are not a significant prognostic index for this tumor.

Translated title of the contribution	The significance of rosette E in women with endometrial cancer: A longitudinal study of 43 cases
Original language	Italian
Pages (from-to)	148-152
Number of pages	5
Journal	Annali di Ostetricia Ginecologia Medicina Perinatale
Volume	103
Issue number	2
Publication status	Published - 1982

ASJC Scopus subject areas

Obstetrics and Gynaecology

Access to Document

Fingerprint Dive into the research topics of 'The significance of rosette E in women with endometrial cancer: A longitudinal study of 43 cases'. Together they form a unique fingerprint.

Cite this

@article{a1fd7c2fdec0439b88ee264f5e204376,

title = "VALUTAZIONE DELLE ROSETTE E IN PAZIENTI PORTATRICI DI CARCINOMA ENDOMETRIALE. (STUDIO LONGITUDINALE DI 43 CASI)",

abstract = "The percentage of Rosette E does not show significant modification in the patients affected with adenocarcinoma of endometrium stage I and II in comparison with a control group. We did not find any modification at the diagnosis, during the follow-up, considering the stage, the cellular differentiation, the myometrial infiltration and the presence or absence of relapses. We think that the endometrial carcinoma can originate and progress independently from the immunological situation of the patient, or that the Rosette E are not a significant prognostic index for this tumor.",

author = "Bolis, {P. F.} and S. Guaschino and M. Franchi and R. Maccario",

year = "1982",

language = "Italian",

volume = "103",

pages = "148--152",

journal = "Annali di Ostetricia Ginecologia Medicina Perinatale",

issn = "0003-4657",

number = "2",

}

TY - JOUR

T1 - VALUTAZIONE DELLE ROSETTE E IN PAZIENTI PORTATRICI DI CARCINOMA ENDOMETRIALE. (STUDIO LONGITUDINALE DI 43 CASI)

AU - Bolis, P. F.

AU - Guaschino, S.

AU - Franchi, M.

AU - Maccario, R.

PY - 1982

Y1 - 1982

N2 - The percentage of Rosette E does not show significant modification in the patients affected with adenocarcinoma of endometrium stage I and II in comparison with a control group. We did not find any modification at the diagnosis, during the follow-up, considering the stage, the cellular differentiation, the myometrial infiltration and the presence or absence of relapses. We think that the endometrial carcinoma can originate and progress independently from the immunological situation of the patient, or that the Rosette E are not a significant prognostic index for this tumor.

AB - The percentage of Rosette E does not show significant modification in the patients affected with adenocarcinoma of endometrium stage I and II in comparison with a control group. We did not find any modification at the diagnosis, during the follow-up, considering the stage, the cellular differentiation, the myometrial infiltration and the presence or absence of relapses. We think that the endometrial carcinoma can originate and progress independently from the immunological situation of the patient, or that the Rosette E are not a significant prognostic index for this tumor.

UR - http://www.scopus.com/inward/record.url?scp=0020318276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020318276&partnerID=8YFLogxK

M3 - Articolo

C2 - 6981371

AN - SCOPUS:0020318276

VL - 103

SP - 148

EP - 152

JO - Annali di Ostetricia Ginecologia Medicina Perinatale

JF - Annali di Ostetricia Ginecologia Medicina Perinatale

SN - 0003-4657

IS - 2

ER -